Immuron Inc (IMRN): Company Projected Revenue

Official company branding of Immuron (IMRN)

Is it worth investing in Immuron Limited (IMRN), which has carved out a niche in protective products for travelers? The company's sales volume expectations provide the answer, where the value 0.01 reflects the metric balance. The business relies on patent protection and complex certifications, which effectively shuts out competitors. Additionally, Immuron Limited (IMRN) is implementing ESG standards, reducing hazardous waste and its carbon footprint during the production of biological preparations.

immuron.com.au - IMRN Projected Sales Volume (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for Immuron Inc (IMRN)

- stock value and consensus price forecast:
Price Chart Immuron Limited|IMRN - Consensus Target
- stock exchange capitalization data:
Market Value Immuron Ltd|IMRN - Real Price to Acquire Entire Company
- balance sheet equity data:
Accounting Value per Share Immuron|IMRN - Book Capitalization|Market Value to Book Value Ratio immuron.com.au|IMRN - Aggregate Asset Value
- issuer credit burden and liquidity indicators:
Debt to Equity Immuron Limited|IMRN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Immuron Limited|IMRN - Company Aggregate Debt|Debt to Book Value Immuron Ltd|IMRN - Company Long-Term Loans and Borrowings|Company Short-Term Debt Immuron|Quick Ratio immuron.com.au
- financial results and valuation multiples details:
IMRN - Net Financial Result|Expected Profit Immuron Limited|IMRN - Price to Earnings Ratio|Forward P/E Multiple Immuron Limited|IMRN - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Immuron Ltd|IMRN - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Immuron|IMRN - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth immuron.com.au|IMRN - Earnings per share growth this year|Earnings growth forecast for next year Immuron Limited
- sales volume and revenue indicators:
IMRN - Company Gross Revenue|Company Projected Revenue Immuron Limited|IMRN - Market Cap to Revenue|Price-to-Projected Revenue Ratio Immuron Ltd
Summary company analytics:Immuron IMRN
Signature product of Immuron Limited

This metric measures the gap between market expectations and actual revenue, determining the issuer's fundamental stability. It serves as a tool for assessing institutional demand and capital freeze risks. By analyzing this sales benchmark for the company on the GURU.Markets platform, an investor can identify the business's expansion potential. For Immuron Limited (IMRN), the upward curve confirms the successful scaling of Travelan products. Expanding the distribution geography directly drives the metric's bullish momentum.

Direct competitors

Company Projected Revenue Phathom Pharmaceuticals (PHAT)|Company Future Sales Volume ternspharma.com TERN|Company Projected Revenue Ironwood Pharmaceuticals, Inc. IRWD|CURX - Company Future Sales Volume|EVOK: Company Future Sales Volume|ENTO - Projected Sales Volume|redhillbio.com (RDHL) - Company Projected Revenue|palisadebio.com - Company Future Revenue|Company Projected Revenue Jaguar Health|Company Expected Sales Volume Biora Therapeutics Inc. BIOR|Company Projected Revenue Morphic Holding Inc (MORF)